(Q33780614)

29 July 2017

1 reference

title

Distinct levels of regulation in organ-specific autoimmune diseases (English)

1 reference

29 July 2017

Kumar V

1

1 reference

29 July 2017

Sercarz E

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

65

1 reference

29 July 2017

issue

15

1 reference

29 July 2017

page(s)

1523-1530

1 reference

The thymus and self-tolerance: co-existence of encephalitogenic S100 beta-specific T cells and their nominal autoantigen in the normal adult rat thymus

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Pancreatic gene expression in rare cells of thymic medulla: evidence for functional contribution to T cell tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

The shaping of the brain-specific T lymphocyte repertoire in the thymus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Positive and Negative CD4+ Thymocyte Selection by a Single MHC Class II/Peptide Ligand Affected by Its Expression Level in the Thymus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Functional diversity of helper T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

CD4+ T-cell subsets in autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

CD4+ T-cells in the regulation of inflammatory responses in the intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Post-thymectomy autoimmunity: abnormal T-cell homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Genetic analysis of autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Mouse CD1-specific NK1 T cells: development, specificity, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Determinant spreading and the dynamics of the autoimmune T-cell repertoire.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Suppression of spontaneous uveoretinitis development by non-immunopathogenic peptide immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

T cell regulatory circuitry: antigen-specific and TCR-idiopeptide-specific T cell interactions in EAE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Dysregulation of potentially pathogenic self reactivity is crucial for the manifestation of clinical autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Neonatal injection of Lewis rats with recombinant V beta 8.2 induces T cell but not B cell tolerance and increased severity of experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

The Th1/Th2 dichotomy, hsp60 autoimmunity, and type I diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

Genetic vaccination: the advantages of going naked

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900198-8

10.1016/S0024-3205(99)00198-8

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference